Analyst Ratings for Aquestive Therapeutics (AQST)
AQST Rating Summary
AQST Price Target Summary
- Highest: $30.00 (Wedbush)
- Lowest: $7.00 (RBC Capital)
- Average: $18.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$18.50 (+357.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$18.50 (+357.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/7/2021 | RBC Capital | Daniel Busb | New Coverage | Outperform (N/A) |
7.00 (N/A) |
5.21 (4.04) |
-22.46% | Details |
| 4/22/2019 | H.C. Wainwright » Updated 12/2/2019 |
Raghuram Selvaraju | New Coverage | Buy (N/A) |
14.00 (12.00) |
6.29 (4.04) |
-35.77% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
